US Stock MarketDetailed Quotes

CRVS Corvus Pharmaceuticals

Watchlist
  • 4.615
  • -0.085-1.80%
Trading Dec 19 12:57 ET
296.56MMarket Cap-4.66P/E (TTM)

Corvus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.49%7.26M
5.57%5.94M
-4.88%6.25M
-28.12%23.41M
-0.26%5.65M
-55.42%5.56M
-19.83%5.62M
-11.32%6.57M
-15.70%32.57M
-16.80%5.67M
Selling and administrative expenses
27.46%2.03M
10.10%1.82M
10.00%2.18M
-15.02%6.88M
4.16%1.65M
-24.34%1.6M
-20.86%1.65M
-14.40%1.98M
-14.90%8.1M
-21.56%1.59M
-General and administrative expense
27.46%2.03M
10.10%1.82M
10.00%2.18M
-15.02%6.88M
4.16%1.65M
-24.34%1.6M
-20.86%1.65M
-14.40%1.98M
-14.90%8.1M
-21.56%1.59M
Research and development costs
31.70%5.22M
3.68%4.11M
-11.30%4.08M
-32.46%16.53M
-1.99%4M
-61.75%3.97M
-19.40%3.97M
-9.92%4.59M
-15.96%24.47M
-14.79%4.08M
Operating profit
-30.49%-7.26M
-5.57%-5.94M
4.88%-6.25M
28.12%-23.41M
0.26%-5.65M
55.42%-5.56M
19.83%-5.62M
11.32%-6.57M
15.70%-32.57M
16.80%-5.67M
Net non-operating interest income expense
33.18%566K
7.69%434K
-15.96%316K
142.20%1.58M
19.50%380K
88.89%425K
303.00%403K
3,318.18%376K
4,460.00%654K
4,075.00%318K
Non-operating interest income
33.18%566K
7.69%434K
-15.96%316K
----
----
88.89%425K
303.00%403K
3,318.18%376K
----
----
Total other finance cost
----
----
----
-142.20%-1.58M
----
----
----
----
-4,460.00%-654K
----
Other net income (expense)
-3,776.07%-33.53M
196.50%1.24M
114.09%236K
44.59%-5.21M
69.07%-1.38M
66.51%-865K
11.45%-1.28M
-87.15%-1.68M
-104.44%-9.4M
-84.78%-4.47M
Gain on sale of security
---32.85M
--1.82M
----
----
----
----
----
----
----
----
Earnings from equity interest
21.16%-682K
55.06%-577K
113.63%236K
47.19%-5.28M
69.73%-1.4M
68.32%-865K
19.55%-1.28M
-66.28%-1.73M
-107.10%-10.01M
-81.24%-4.64M
Special income (charges)
----
----
----
--0
----
----
----
----
--22K
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
--22K
----
Other non- operating income (expenses)
----
----
----
-86.71%78K
-85.14%22K
----
----
-61.64%56K
149.79%587K
4.96%148K
Income before tax
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Income tax
Net income
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Net income continuous Operations
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Minority interest income
Net income attributable to the parent company
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-570.28%-40.22M
34.46%-4.26M
27.59%-5.7M
34.57%-27.03M
32.22%-6.65M
59.54%-6M
22.24%-6.5M
5.11%-7.87M
4.47%-41.31M
-6.28%-9.82M
Basic earnings per share
-400.00%-0.6
50.00%-0.07
29.41%-0.12
37.08%-0.56
38.10%-0.13
62.50%-0.12
22.22%-0.14
5.56%-0.17
13.59%-0.89
-5.00%-0.21
Diluted earnings per share
-400.00%-0.6
50.00%-0.07
29.41%-0.12
37.08%-0.56
38.10%-0.13
62.50%-0.12
22.22%-0.14
5.56%-0.17
13.59%-0.89
-5.00%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.49%7.26M5.57%5.94M-4.88%6.25M-28.12%23.41M-0.26%5.65M-55.42%5.56M-19.83%5.62M-11.32%6.57M-15.70%32.57M-16.80%5.67M
Selling and administrative expenses 27.46%2.03M10.10%1.82M10.00%2.18M-15.02%6.88M4.16%1.65M-24.34%1.6M-20.86%1.65M-14.40%1.98M-14.90%8.1M-21.56%1.59M
-General and administrative expense 27.46%2.03M10.10%1.82M10.00%2.18M-15.02%6.88M4.16%1.65M-24.34%1.6M-20.86%1.65M-14.40%1.98M-14.90%8.1M-21.56%1.59M
Research and development costs 31.70%5.22M3.68%4.11M-11.30%4.08M-32.46%16.53M-1.99%4M-61.75%3.97M-19.40%3.97M-9.92%4.59M-15.96%24.47M-14.79%4.08M
Operating profit -30.49%-7.26M-5.57%-5.94M4.88%-6.25M28.12%-23.41M0.26%-5.65M55.42%-5.56M19.83%-5.62M11.32%-6.57M15.70%-32.57M16.80%-5.67M
Net non-operating interest income expense 33.18%566K7.69%434K-15.96%316K142.20%1.58M19.50%380K88.89%425K303.00%403K3,318.18%376K4,460.00%654K4,075.00%318K
Non-operating interest income 33.18%566K7.69%434K-15.96%316K--------88.89%425K303.00%403K3,318.18%376K--------
Total other finance cost -------------142.20%-1.58M-----------------4,460.00%-654K----
Other net income (expense) -3,776.07%-33.53M196.50%1.24M114.09%236K44.59%-5.21M69.07%-1.38M66.51%-865K11.45%-1.28M-87.15%-1.68M-104.44%-9.4M-84.78%-4.47M
Gain on sale of security ---32.85M--1.82M--------------------------------
Earnings from equity interest 21.16%-682K55.06%-577K113.63%236K47.19%-5.28M69.73%-1.4M68.32%-865K19.55%-1.28M-66.28%-1.73M-107.10%-10.01M-81.24%-4.64M
Special income (charges) --------------0------------------22K----
-Gain on sale of property,plant,equipment --------------0------------------22K----
Other non- operating income (expenses) -------------86.71%78K-85.14%22K---------61.64%56K149.79%587K4.96%148K
Income before tax -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Income tax
Net income -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Net income continuous Operations -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Minority interest income
Net income attributable to the parent company -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -570.28%-40.22M34.46%-4.26M27.59%-5.7M34.57%-27.03M32.22%-6.65M59.54%-6M22.24%-6.5M5.11%-7.87M4.47%-41.31M-6.28%-9.82M
Basic earnings per share -400.00%-0.650.00%-0.0729.41%-0.1237.08%-0.5638.10%-0.1362.50%-0.1222.22%-0.145.56%-0.1713.59%-0.89-5.00%-0.21
Diluted earnings per share -400.00%-0.650.00%-0.0729.41%-0.1237.08%-0.5638.10%-0.1362.50%-0.1222.22%-0.145.56%-0.1713.59%-0.89-5.00%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+2.44%
Amazon
AMZN
+1.99%
Alphabet-A
GOOGL
+1.24%
Petroleo Brasileiro SA Petrobras
PBR
+1.05%
Alphabet-C
GOOG
+0.97%

Unlock the Full List